HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.

Abstract
Medullary thyroid carcinoma (MTC) is a neuroendocrine (NE) malignancy that frequently metastasizes and has limited treatments. We recently reported that ectopic expression of Notch-1 in human MTC cells suppresses growth. The objective of this study was to evaluate the ability of suberoyl bis-hydroxamic acid (SBHA) to modulate Notch-1 signaling in MTC cells. At baseline, no active Notch-1 protein was present in MTC cells. Treatment with SBHA resulted in a dose-dependent induction of the Notch-1 intracellular domain, the active form of the protein. Furthermore, with Notch-1 activation there was a concomitant decrease in achaete-scute complex-like 1 (ASCL-1), a downstream target of Notch-1 signaling, as well as the NE tumor marker chromogranin A (CgA). Transfection of Notch-1 small-interfering RNA into MTC cells blocked the effects of SBHA on Notch-1 activation, ASCL-1, and CgA. Importantly, SBHA treatment resulted in a dose-dependent decrease in cell viability. Treated cells had an increase in protein levels of cleaved caspase-3 and poly ADP-ribose polymerase, and changes in the expression of apoptotic mediators including Bcl-X(L) and Bad, indicating that the growth inhibition was a result of apoptosis. These results demonstrate that SBHA activates Notch-1 signaling, which is associated with the antiproliferative and apoptotic effects in MTC cells. Therefore, Notch-1 activation with SBHA is an attractive new strategy for the treatment of patients with MTC.
AuthorsLi Ning, David Yu Greenblatt, Muthusamy Kunnimalaiyaan, Herbert Chen
JournalThe oncologist (Oncologist) Vol. 13 Issue 2 Pg. 98-104 (Feb 2008) ISSN: 1083-7159 [Print] England
PMID18305053 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Biomarkers, Tumor
  • Chromogranin A
  • Hydroxamic Acids
  • NOTCH1 protein, human
  • Receptor, Notch1
  • suberoyl bis-hydroxamic acid
  • Poly(ADP-ribose) Polymerases
  • Caspase 3
Topics
  • Antineoplastic Agents (pharmacology)
  • Apoptosis (drug effects)
  • Biomarkers, Tumor (metabolism)
  • Blotting, Western
  • Carcinoma, Medullary (drug therapy, metabolism, physiopathology)
  • Caspase 3 (metabolism)
  • Cell Proliferation (drug effects)
  • Chromogranin A (metabolism)
  • Down-Regulation
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Hydroxamic Acids (pharmacology)
  • Poly(ADP-ribose) Polymerases (drug effects)
  • Receptor, Notch1 (drug effects, metabolism)
  • Signal Transduction (drug effects)
  • Thyroid Neoplasms (drug therapy, metabolism, physiopathology)
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: